Sales grew 20%+ in the second half of Q1, June and July accelerating into festive season, 371,000 direct outlets and adding 50,000 more in FY27
The headline Q1FY27 numbers for Bikaji Foods — revenue growth of 12.5%, EBITDA up just 3%, PAT flat year-on-year — do not capture the story that management’s earnings call told. The quarter started slowly, weighed down by 10-15 days of production loss at the Bikaner facility, adverse weather affecting papad sales, and US tariff-related uncertainty weighing on exports.
But the back-half of Q1 recovered strongly — sales grew 20%+ — and June and July have seen a strong secondary and tertiary demand pickup heading into the festive season. Systematix Institutional Equities maintains BUY with a revised target of Rs 740, building FY26-29 ex-PLI revenue and EPS CAGRs of 14% and 18% respectively.
The Quarter Behind the Quarter
The reported numbers require context to be read correctly. Ethnic snacks grew 11% year-on-year — below the company’s usual pace, primarily because of the production disruption at Bikaner. Management has now planned to manufacture Bhujia at an alternate location, which should prevent a recurrence. Western snacks grew a stronger 21% year-on-year, reflecting the category momentum that Bikaji has been building through product and distribution investment. Sweets grew 4% year-on-year — slower than the 12-15% management expects going forward as seasonal and operational factors normalised.
Gross margins expanded 70 basis points year-on-year to 35% — a resilient performance against a backdrop of elevated edible oil and pulse costs. Operating margins came in at 13.5% — down 130 basis points year-on-year but up 130 basis points sequentially — with the year-on-year decline explained by higher A&P spend of 40-50 basis points and slightly elevated manufacturing costs of 30-40 basis points. “Resilient margins despite sharp input-cost escalation indicates strength in turbulent times,” Systematix notes — and the two price hikes of approximately 4% taken in the last three to four months provide further cover against input cost pressure through the festive period.
The Distribution Machine
The metric that best captures Bikaji’s medium-term growth trajectory is direct distribution reach — currently at 371,000 outlets, having added 17,200 in Q1FY27 alone. The plan is to add 50,000 outlets in FY27 to reach 400,000 by year-end, with a three-year target of 500,000. For an FMCG company in the ethnic snacks category — where availability at the neighbourhood store is the primary purchase driver — this distribution buildout is the most important organic growth investment the company is making.
Focus states — approximately 15% of sales — are growing at 20-25%, or roughly twice the pace of core states. The salience of non-core states has already risen from approximately 30% in FY25 to 34% in FY26. “Distribution expansion is on track, with planned addition of 50k outlets in FY27 to achieve direct reach of 400k by year-end,” the report notes — a systematic penetration of underdeveloped geographies that is structurally accretive to volume growth.
The Festive Season
Management’s commentary on the demand outlook ahead of the festive season is notably specific rather than generic. June and July witnessed “strong secondary and tertiary demand pickup across ethnic and western snacks” — a signal that retailer restocking and end-consumer demand are both building simultaneously. The company plans a “further thrust on A&P spend in the next few quarters” — brand-building investment that is calibrated to the festive calendar and timed to convert the demand pickup into market share gains. A&P for the full year is guided at 2% of sales — elevated versus recent years but disciplined within a range that management is comfortable sustaining.
No further price hikes are planned until Diwali — a deliberate decision to keep the product affordable and momentum-supportive through the peak selling season. The combination of price stability, stronger advertising and improving distribution is the demand management playbook that has worked for Bikaji in prior festive cycles.
The Adjacent Category Opportunity
Beyond the core ethnic snacks business, Bikaji is building meaningful positions in adjacent high-growth categories — retail and QSR supply, frozen foods and bakery — that collectively contributed approximately 7% of FY26 sales. Systematix expects this to grow to approximately 10% in FY27 and 12% in FY28, adding a layer of revenue diversification that reduces dependence on the core snacks cycle. These categories carry different margin and volume dynamics from ethnic snacks and provide Bikaji with exposure to the growing out-of-home consumption trend.
The pack and SKU mix story is also accretive. The salience of large packs has grown from approximately 60% to 62% in FY26 — “far superior versus industry,” Systematix notes. Large packs carry better per-unit economics and are the format of choice for the quality-conscious, value-seeking consumer that Bikaji has been successfully targeting. The current low-capex, high-free-cash-flow phase — with capacity utilisation set to improve over the next two to three years — means this margin improvement flows through with minimal dilutive reinvestment.
Scorecard
| Metric | Value |
|---|---|
| Current Market Price | Rs 624 |
| Target Price | Rs 740 (revised from Rs 750) |
| Upside | ~19% |
| Rating | BUY (Maintained) |
| Valuation | 50x Jun-28E P/E |
| Q1FY27 Revenue Growth | 12.5% YoY |
| Q1FY27 Volume Growth | 8% YoY |
| Western Snacks Growth | 21% YoY |
| FY27 Revenue Growth Guidance | 15%+ |
| Direct Distribution Reach | 371,000 outlets |
| FY27 Outlet Addition Target | 50,000 |
| Revenue CAGR FY26-29E | 14% |
| EPS CAGR FY26-29E | 18% |
| FY29E RoE | 18.1% |
Systematix lowers FY27-28 estimates by 2-3% to factor in the Q1 softness, introduces FY29 estimates, and rolls the valuation base forward to June 2028. The 50x P/E multiple — broadly in line with the current one-year forward multiple — is maintained, reflecting the quality and growth visibility of the franchise. At 19% upside to target and with 18% EPS CAGR through FY29, Systematix’s has made a case for owning this quality compounder through a temporarily soft quarter rather than selling it.